Send to a Friend Share

Notable Analyst Rating Changes 8/10: NZ, LINTA, HEW Upgraded; HANS, WTI, BBY Downgraded

August 10, 2009 10:34 AM EDT
NZ Hot Sheet
Overall Analyst Rating:
    NEUTRAL (= Flat)
UPGRADES:

Baird upgrades Netezza (NYSE: NZ) from Neutral to Outperform. Price target increased from $7 to $14.

JP Morgan upgrades Liberty Media Interactive (Nasdaq: LINTA) from Neutral to Overweight and raises their price target from $7 to $13.

UBS upgrades Hewitt Associates (NYSE: HEW) from Neutral to Buy. Price target $39.

For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades

DOWNGRADES:
Longbow Research downgrades Hansen Natural (Nasdaq: HANS) from Buy to Neutral.

BMO Capital downgrades W&T Offshore (NYSE: WTI) from Market Perform to Underperform.

Goldman Sachs downgrades Best Buy Co. Inc. (NYSE: BBY) from Buy to Neutral. The firm said although they expect BBY to have a great year, they see challenges including competition from the mass market and online, product mix and aggressive investment in growth.

Goldman Sachs downgrades King Pharmaceuticals Inc. (NYSE: KG) to Neutral and removes the stock from its Conviction Buy List. The firm cited only modest upside to its $11 price target.

For daily real-time Downgrades go to http://www.streetinsider.com/Downgrades

NEW COVERAGE:

Goldman Sachs initiates coverage on Medicis Pharmaceutical Corp. (NYSE: MRX) with a Buy rating and $25 price target, suggesting over 30% upside. The firm said although the shares have rallied significantly they are still undervalued as investors underestimate the commercial potential of Lipoxonix, they have high expectations for Dysport, and said concerns surrounding Solodyn's IP and long-term sustainability are still overdone.

Goldman Sachs initiates coverage on Allergan Inc. (NYSE: AGN) with a Neutral and $60 price target. The firm said while Allergan is one of the best specialty pharma companies in their universe, this is already reflected in the current stock price.

Longbow Research initiates coverage on American States Water Company (NYSE: AWR) with a Neutral. Price target $45.

For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage

You May Also Be Interested In


Related Categories

Special Reports

Related Entities

Goldman Sachs Conviction Buy List, UBS, JPMorgan, Robert W Baird, BMO Capital, Longbow Research, Notable Analyst Rating Changes

Add Your Comment





Follow StreetInsider.com On Twitter